Despite recent advances in surgery, and more aggressive resection, liver metastases still prove fatal in a high proportion of cases. This volume aims to enhance our understanding of the biology of hepatic cancer metastasis, in particular its early stages.

Liver metastases are a frequent and often fatal occurrence in cancer patients, particularly those with malignancies of the gastrointestinal (GI) tract. While recent improvements in surgical techniques and a more aggressive approach to resection of liver metastases have improved long term survival for some patients, most patients with hepatic metastases still succumb to their disease. To improve these dismal statistics, a better understanding of the biology of liver metastasis, particularly the early stages that can be targeted for prevention, is essential.

Once cancer cells enter the liver, several different scenarios may occur. The cancer cells may be immediately destroyed by local defence mechanisms, they may enter a state of dormancy as solitary cells and never produce a metastasis, initiate a short-lived process of proliferation that is aborted before a metastasis is established or actively proliferate to form macrometastases. The chapters in Part I of this book provide insight into the cellular/molecular mechanisms that determine which of these scenarios prevails. Written by experts researchers in the filed of metastasis, these chapters provide state-of-the art reviews on the cellular and molecular processes that impact the early stages of the metastatic process. The unique microenvironment of the liver, its various anatomical, cellular and molecular features and the impact they have on metastasis are highlighted. In addition, the role of inflammation (pre-existing and tumor-induced), host innate and adaptive immune responses, cytokines, chemokines, growth factors and the unique molecular signatures of metastatic tumor cells are reviewed with an underscoring of thetranslational implications of the current state of knowledge.

Against this background, the chapters in Part II of the book provide critical reviews on major aspects of the clinical management of hepatic metastases. These include imaging strategies, surgical and chemotherapeutic treatment approaches and the use of targeted biological therapeutics such as anti-angiogenic drugs as treatment modalities.

By combining information on biological and clinical aspects of liver metastasis, this volume will serve as an excellent resource for scientists, clinicians, clinician/ scientists and trainees in the domains of oncology, surgical oncology, hepatobiliary physiology and radiology.

Comprehensive and timely reviews on different aspects of the Biology of liver metastasis A unique combination of chapters on basic biological mechanisms and clinical aspects of liver metastasis written by experts in the respective fields Unlike other books now available on this subject, this book is not restricted to colon or GI cancers in its focus The Book will appeal to clinicians and laboratory scientists as well as trainees in both disciplines

Inhalt

BIOLOGY. 1. Cellular and molecular aspects of the liver architecture and function. 2. The tumor microenvironment at different stage of hepatic metastasis. 3. The Colorectal Cancer Initiating Cell: Markers and their role of in liver metastasis . 4. Role of CXC chemokines and receptors in liver metastasis impact on liver resection-induced engraftment and tumor growth . 5. Role of Inflammation in the early stages of liver metastasis. 6. Signal transduction in tumor-endothelial cell communication . 7. Tumor dormancy in liver metastasis: clinical and experimental evidence and implications for treatment. 8. Role of the IGF- axis in liver metastasis: experimental and clinical evidence. 9. Breast Cancer Liver Metastasis. **** CLINICAL MANAGEMENT. 10. Imaging of Hepatic Metastases. 11. Colorectal Carcinoma Liver Metastasis: Surgical Clinical Perspective. 12. Evaluation and Management of Liver Metastases from Non-Gastrointestinal Cancer. 13. Proteomic profiling of hepatic metastases: Paving the way to individualized therapy. 14. Targeting Angiogenesis in the Treatment of Hepatic Metastasis. 15. Uveal melanoma a paradigm of site-specific liver metastasis.